Two Eye-Catching Stocks: Teva Pharmaceutical Industries Limited (NYSE:TEVA), Regions Financial Corporation (NYSE:RF)

earning reaction history

Teva Pharmaceutical Industries Limited (NYSE:TEVA)

The company announced its last quarter financial performance results on 11/15/2016. Teva Pharmaceutical Industries Limited (NYSE:TEVA) belongs to Medical sector that surged 0.59% in value when last trading session closed at $32.38. The company has a market capitalization of $32.51 Billion. The company’s stock has a Return on Assets (ROA) of 2.4 percent, a Return on Equity (ROE) of 5.7 percent and Return on Investment (ROI) of 5.7 percent. The company reached its 52-Week high of $59.35 on Mar 11, 2016 and 52-Week low of $31.9 on Feb 8, 2017.

Earnings per share (ttm) for Teva Pharmaceutical Industries Limited (NYSE:TEVA) according to Finviz Data is $1.73.

The growth estimate for Teva Pharmaceutical Industries Limited (NYSE:TEVA) for the current quarter is 5.5 percent. The projected growth estimate for the next quarter is -4.2 percent. The company’s stock has grown by -0.84 percent in the past 5 years. For the next 5 years, the company is expected to grow by 0.43 percent.

This company was Upgrade by BofA/Merrill on 31-Jan-17  to Buy.

The 25 analysts offering 12-month price forecasts for Teva Pharmaceutical have a median target of 42.00, with a high estimate of 80.00 and a low estimate of 35.00. The median estimate represents a +29.71% increase from the last price of 32.38.

Financial History:

Following Earnings result, share price were DOWN 13 times out of last 19 Qtrs. In the last 27 earnings reports, the company has topped earnings-per-share estimates 75% percent of times. It has met expectations  2  times and missed earnings  1 times.

The consensus recommendation for Teva Pharmaceutical Industries Limited (NYSE:TEVA) is 2.19. The rating scale runs from 1 to 5 with 5 indicating a Strong Sell, 1 indicating a Strong Buy and 3 indicating a Hold. The consensus recommendation 30 days ago for this company stood at 2.06. In comparison, the consensus recommendation 60 days ago was at 1.91, and 90 days ago was at 1.68 respectively.

Future Expectations:

When the current quarter ends, Wall Street expects Teva Pharmaceutical Industries Limited to have earnings per share of $1.35.

Revenue is expected to range from 6 Billion to 6.42 Billion with an average of 6.25 Billion.

Company Profile:

TEVA Pharmaceuticals USA, the business is to develop, manufacture, and market generic pharmaceuticals.  Teva USA sells its products to chains, wholesalers, distributors, hospitals, managed care entities, and government agencies.  The company markets a variety of dosage forms, including both extended and immediate release tablets and capsules, creams, ointments, solutions, and suspensions.  Key therapeutic areas are the analgesic, anti-infective, cardiovascular, CNS, dermatological and anti-inflammatory categories.

Regions Financial Corporation (NYSE:RF):

Regions Financial Corporation (NYSE:RF) belongs to Finance sector closed its last session with a loss of -0.62 percent and closed its previous trading session at $14.49. According to Finviz reported data, the stock currently has Earnings per Share (EPS) (ttm) of $0.87. The company has the Market capitalization of $17.74 Billion. The company’s stock has a Return on Assets (ROA) of 0.9 percent, a Return on Equity (ROE) of 6.7 percent and Return on Investment (ROI) of 11.1 percent. The company reached its 52-Week high of $14.93 on Jan 13, 2017 and 52-Week low of $7 on Feb 11, 2016.

The growth estimate for Regions Financial Corporation (NYSE:RF) for the current quarter is 15 percent. The projected growth estimate for the next quarter is 20 percent. The company’s stock has grown by 5.03 percent in the past 5 years. For the next 5 years, the company is expected to grow by 6 percent.

This company was Downgrade by Susquehanna on 1-Dec-16 to Neutral.

The 28 analysts offering 12-month price forecasts for Regions Financial Corp have a median target of 15.00, with a high estimate of 19.00 and a low estimate of 11.00. The median estimate represents a +3.52% increase from the last price of 14.49.

Financial History:

Following Earnings result, share price were UP 16 times out of last 28 Qtrs. In the last 27 earnings reports, the company has topped earnings-per-share estimates 50% percent of times. It has met expectations  3  times and missed earnings  3  times.

The consensus recommendation for Regions Financial Corporation (NYSE:RF) is 2.91. The rating scale runs from 1 to 5 with 5 indicating a Strong Sell, 1 indicating a Strong Buy and 3 indicating a Hold. The consensus recommendation 30 days ago for this company stood at 2.8. In comparison, the consensus recommendation 60 days ago was at 2.58, and 90 days ago was at 2.58 respectively.

Future Expectations:

When the current quarter ends, Wall Street expects Regions Financial Corporation to have earnings per share of $0.23.

Revenue is expected to range from 1.37 Billion to 1.42 Billion with an average of 1.39 Billion.

Company Profile:

Regions Financial Corporation is a regional bank holding company and has banking-related subsidiaries engaged in mortgage banking, credit life insurance, leasing, and securities brokerage activities with offices in various Southeastern states. Through its subsidiaries, Regions offers a broad range of banking and banking-related services.

You may missed